• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汗孔角化症中的p53、mdm - 2和p21 waf - 1

p53, mdm-2, and p21 waf-1 in the porokeratoses.

作者信息

Nelson C, Cowper S, Morgan M

机构信息

Department of Pathology, University of South Florida College of Medicine, Tampa, USA.

出版信息

Am J Dermatopathol. 1999 Oct;21(5):420-5. doi: 10.1097/00000372-199910000-00003.

DOI:10.1097/00000372-199910000-00003
PMID:10535569
Abstract

The etiology of the porokeratoses is unknown. Overexpression of the p53 tumor suppressor protein and disregulated cell cycle control have been pathogenically implicated. The p53 tumor suppressor gene product is regulated by mdm2 and both gene products influence cell cycle progression through the cyclin-dependent kinase inhibitor p21. Thirty-three cases of the various types of porokeratosis were immunohistochemically studied for p53, mdm2, and p21 proteins. Each of the cases showed increased p53 and decreased mdm2 and p21 expression within keratinocytes underlying cornoid lamella. This study confirms the previous findings of increased p53 staining and expands the potential roles of mdm2 and p21 in the pathogenesis of the porokeratoses.

摘要

汗孔角化症的病因尚不清楚。p53肿瘤抑制蛋白的过度表达和细胞周期调控失调在发病机制上与之相关。p53肿瘤抑制基因产物受mdm2调控,且这两种基因产物均通过细胞周期蛋白依赖性激酶抑制剂p21影响细胞周期进程。对33例不同类型的汗孔角化症进行了p53、mdm2和p21蛋白的免疫组织化学研究。每例病例在鸡眼样板下方的角质形成细胞中均显示p53表达增加,mdm2和p21表达降低。本研究证实了先前p53染色增加的发现,并扩展了mdm2和p21在汗孔角化症发病机制中的潜在作用。

相似文献

1
p53, mdm-2, and p21 waf-1 in the porokeratoses.汗孔角化症中的p53、mdm - 2和p21 waf - 1
Am J Dermatopathol. 1999 Oct;21(5):420-5. doi: 10.1097/00000372-199910000-00003.
2
Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.p53、mdm2、p21/Waf-1、Rb、p16、Ki67、细胞周期蛋白D1、细胞周期蛋白A和细胞周期蛋白B1蛋白在T细胞淋巴瘤中的免疫组化表达及凋亡指数
Histol Histopathol. 2001 Apr;16(2):377-86. doi: 10.14670/HH-16.377.
3
Mdm2 and the p53 pathway in human pituitary adenomas.人垂体腺瘤中的Mdm2与p53信号通路
Clin Endocrinol (Oxf). 2001 Mar;54(3):317-25. doi: 10.1046/j.1365-2265.2001.01195.x.
4
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.小细胞肺癌中bcl2、p53、mdm2和p21/waf1蛋白的免疫组织化学检测
Anticancer Res. 1998 Mar-Apr;18(2A):1167-73.
5
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.小细胞肺癌中bcl2、p53、mdm2和p21/waf1蛋白的免疫组织化学检测
Anticancer Res. 1998 May-Jun;18(3A):1689-95.
6
Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.黏膜相关淋巴组织(MALT)淋巴瘤中p53、p21、mdm2、Rb、bax和Ki67蛋白的表达
Anticancer Res. 1998 Jul-Aug;18(4A):2403-8.
7
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.乳腺癌中p53蛋白的表达。与野生型p53诱导蛋白mdm2和p21/waf1的比较研究。
Anticancer Res. 1997 May-Jun;17(3C):2123-7.
8
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.骨髓活检中p53、mdm2、waf1/p21和Ki67蛋白在骨髓增生异常综合征、急性髓系白血病和慢性骨髓增殖性疾病中的免疫组织化学检测
Clin Exp Pathol. 1999;47(5):231-8.
9
p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.p21(Waf1/Cip1)表达及p53/MDM2反馈环在胃癌发生中的作用
J Pathol. 1999 Dec;189(4):481-6. doi: 10.1002/(SICI)1096-9896(199912)189:4<481::AID-PATH482>3.0.CO;2-U.
10
Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.基于p53、MDM2和p21表型的低分期膀胱癌的致瘤途径。
J Urol. 2001 May;165(5):1811-2. doi: 10.1016/s0022-5347(05)66418-x.

引用本文的文献

1
Disseminated Superficial Porokeratosisin a Patient with Gastric Cancer.一名胃癌患者的播散性浅表性汗孔角化症
Ann Dermatol. 2008 Dec;20(4):193-6. doi: 10.5021/ad.2008.20.4.193. Epub 2008 Dec 31.